Is the Cardiometabolic index associated with the risk of new-onset chronic diseases?
The Cardiometabolic index (CMI) is significantly associated with the risk of developing new-onset chronic diseases, highlighting its potential as an early risk marker.
CMI showed a significant positive association with the risk of new-onset chronic diseases such as hypertension, diabetes, dyslipidemia, and liver disease. Future applications of CMI hold promise as an effective marker for early identification of chronic disease risk.
Zhuo et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: